Mycophenolate mofetil for Crohn's disease: short‐term efficacy and long‐term outcome

Abstract

Mycophenolate mofetil was initially effective in a sizeable fraction of patients with complicated Crohn's disease, but relapse within 18 months was common. Nevertheless, mycophenolate mofetil could be a useful alternative in patients intolerant to azathioprine.